Ventyx Biosciences Inc (NASDAQ:VTYX) currently has a daily average trading volume of 1.15M but it saw 8010999 shares traded in last market. With a market cap of 129.51M USD, the company’s current market price of $1.82 came rising about 18.95 while comparing to the previous closing price of $1.53. In past 52 weeks, the stock remained buoying in the range of price level as high as $5.66 and as low as $0.78.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Wells Fargo which upgraded the stock as “Overweight” in its note to investors issued on March 12, 2024, recommending a price target of between $7 and $16 for it. Oppenheimer upgraded its recommendation for the stock as a “Outperform” from “Perform” on March 12, 2024 while assigning a price target of $12. Wells Fargo issued its recommendations for the stock as it downgraded the price target for the stock in the range of between $77 and $8.
Over the week, VTYX’s stock price is moving 50.41% up while it is 56.90% when we observe its performance for the past one month. Year-to-date it is -16.89% down and over the past year, the stock is showing a downside performance of -62.32%.
Currently, Ventyx Biosciences Inc’s total number of outstanding shares is 71.16M with 4.14% of that held by the insiders while 68.49% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -51.43% and return on equity (ROE) at -46.04%. Stock’s beta reads 0.87. Stock has a price to book (P/B) ratio of 0.56. Its return on asset (ROA) is -42.35% on average.
